+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Manufacturing Market by Formulation, Drug Development Type, Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2025-2030- Product Image
Pharmaceutical Manufacturing Market by Formulation, Drug Development Type, Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Manufacturing Market by Formulation, Drug Development Type, Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5896347
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Manufacturing Market grew from USD 620.68 billion in 2023 to USD 672.44 billion in 2024. It is expected to continue growing at a CAGR of 8.66%, reaching USD 1.11 trillion by 2030.

The scope of pharmaceutical manufacturing encompasses the production of medications on a large scale, involving complex processes to ensure efficacy, safety, and compliance with regulatory standards. It is vital for public health systems globally, fulfilling the necessity for advanced, effective treatments for diverse medical conditions. The application extends across multiple therapeutic areas, such as oncology, cardiovascular diseases, and infectious diseases, targeting both chronic and acute conditions. The end-use scope includes hospitals, clinics, retail pharmacies, and research institutes. Market growth is significantly influenced by factors such as the increasing prevalence of chronic diseases, advancements in biopharmaceuticals, and growing investment in R&D. Technological innovations like AI, big data, and IoT are creating new opportunities by enhancing production efficiency and drug discovery processes. To capitalize on these, companies should focus on integrating these technologies into their operations and investing in personalized medicine and biosimilars, which represent significant growth opportunities due to their potential to improve treatment outcomes and reduce costs. However, the market faces limitations, such as stringent regulatory environments, high costs of drug development, and patent expirations which can lead to revenue losses. Furthermore, challenges like supply chain disruptions and the need for significant capital investment in infrastructure and technology can hinder growth. To overcome these, companies should explore partnerships and collaborations for shared resources and expertise. Innovation in areas like green chemistry, continuous manufacturing, and digital transformation through blockchain for supply chain transparency can drive future growth. The market is highly competitive and dynamic but offers vast opportunities for companies that prioritize R&D, adapt to regulatory changes, and align with emerging trends like sustainable manufacturing and patient-centric approaches. Fostering innovation and maintaining responsiveness to market demands are key for resilience and sustained growth in the pharmaceutical manufacturing sector.

Understanding Market Dynamics in the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increase in global demand for vaccines and drugs
    • Growing pharmaceutical R&D spending
    • Growth in geriatric population and incidence rate of chronic disorders
  • Market Restraints
    • High costs and complexities associated with the pharma production
  • Market Opportunities
    • Rise in the investment and funding programs in the pharmaceutical manufacturing sector
    • Emergence of novel pharmaceutical manufacturing technologies
  • Market Challenges
    • Stringent government regulations for pharmaceutical companies

Exploring Porter’s Five Forces for the Pharmaceutical Manufacturing Market

Porter’s Five Forces framework further strengthens the insights of the Pharmaceutical Manufacturing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pharmaceutical Manufacturing Market

External macro-environmental factors deeply influence the performance of the Pharmaceutical Manufacturing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Lupin Limited, Piramal Pharma Limited, Asymchem, Inc., Recipharm AB, Biocon Limited, AbbVie Inc., Bayer AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Pfizer, Inc., Merck KGaA, Amgen Inc., Advent Pharma Ltd., Johnson & Johnson Services, Inc., Azurity Pharmaceuticals, Inc., Famar Group, Zeon Lifesciences Ltd., Actiza Pharmaceutical Pvt. Ltd., Cipla Limited, Aenova Group GmbH, Boehringer Ingelheim International GmbH, Moderna, Inc., Thermo Fisher Scientific Inc., Sun Pharmaceutical Industries Ltd., BioNTech SE, Lonza Group AG, Novartis AG, F. Hoffmann-La Roche Ltd., Emcure Pharmaceuticals Limited, Veranova, L.P., Bristol-Myers Squibb Company, Gilead Sciences, Inc., Sanofi S.A., Novo Nordisk A/S, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, GlaxoSmithKline PLC, and McKesson Corporation.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Formulation
    • Capsules
    • Injectable
    • Powders
    • Sprays
    • Suspensions
    • Tablets
  • Drug Development Type
    • In-House
    • Outsource
  • Route of Administration
    • Inhalations
    • Oral
    • Parenteral
    • Topical
  • Drugs
    • Over-the-Counter (OTC) Medicines
    • Prescription Medicines
  • Age Group
    • Adults
    • Children & Adolescents
    • Geriatric
  • Distribution Channel
    • Non-Retail
    • Retail
  • Therapy Area
    • Allergy
    • Cardiovascular Diseases
    • Dermatology
    • Diabetes
    • Gastroenterology
    • Infectious Disease
    • Neurology
    • Oncology
    • Ophthalmology
    • Pain Management
    • Psychiatry
    • Pulmonary
    • Renal Disease
    • Respiratory Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in global demand for vaccines and drugs
5.1.1.2. Growing pharmaceutical R&D spending
5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
5.1.2. Restraints
5.1.2.1. High costs and complexities associated with the pharma production
5.1.3. Opportunities
5.1.3.1. Rise in the investment and funding programs in the pharmaceutical manufacturing sector
5.1.3.2. Emergence of novel pharmaceutical manufacturing technologies
5.1.4. Challenges
5.1.4.1. Stringent government regulations for pharmaceutical companies
5.2. Market Segmentation Analysis
5.2.1. Formulation: Surging investment to support robust research and development of injectable formulations
5.2.2. Drug Development Type: Increasing use of outsourced pharmaceutical manufacturing due to its cost effectiveness
5.2.3. Route of Administration: Rising research and development activities parenteral drug delivery with rising prevalence of chronic disease
5.2.4. Drugs: Inclination toward Over-the-counter (OTC) drugs
5.2.5. Age Group: Significant need for drug formulations to treat geriatric medical conditions
5.2.6. Distribution Channel: Penetration of non-retail distribution channels for pharmaceuticals
5.2.7. Therapy Area: Wave of innovations toward development of new oncology treatment modalities
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
5.5.1. List of Top Selling Prescription and Over-the-Counter Drugs in 2022
6. Pharmaceutical Manufacturing Market, by Formulation
6.1. Introduction
6.2. Capsules
6.3. Injectable
6.4. Powders
6.5. Sprays
6.6. Suspensions
6.7. Tablets
7. Pharmaceutical Manufacturing Market, by Drug Development Type
7.1. Introduction
7.2. In-House
7.3. Outsource
8. Pharmaceutical Manufacturing Market, by Route of Administration
8.1. Introduction
8.2. Inhalations
8.3. Oral
8.4. Parenteral
8.5. Topical
9. Pharmaceutical Manufacturing Market, by Drugs
9.1. Introduction
9.2. Over-the-Counter (OTC) Medicines
9.3. Prescription Medicines
10. Pharmaceutical Manufacturing Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Children & Adolescents
10.4. Geriatric
11. Pharmaceutical Manufacturing Market, by Distribution Channel
11.1. Introduction
11.2. Non-Retail
11.3. Retail
12. Pharmaceutical Manufacturing Market, by Therapy Area
12.1. Introduction
12.2. Allergy
12.3. Cardiovascular Diseases
12.4. Dermatology
12.5. Diabetes
12.6. Gastroenterology
12.7. Infectious Disease
12.8. Neurology
12.9. Oncology
12.10. Ophthalmology
12.11. Pain Management
12.12. Psychiatry
12.13. Pulmonary
12.14. Renal Disease
12.15. Respiratory Diseases
13. Americas Pharmaceutical Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Pharmaceutical Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.3.1. INR 15,000 Crore Proposed in Pharma Sector, India
16.3.2. Glenmark Pharma Launches Triple-Drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes
16.3.3. Novo, Torrent may Widen Tie-Up
16.3.4. U.S. FDA Approves Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
16.3.5. Finnish Manufacturing Facility to Get EUR 50 Million Expansion
16.3.6. Aenova and Galvita Enter Strategic Partnership
16.3.7. Novo Nordisk Invests EUR 2.1 Billion in Hillerød Manufacturing Expansion
16.3.8. Eli Lilly Adds USD 1.6 Billion to its Manufacturing Spending Plan in Indiana
16.3.9. FDA Approves Novartis Millburn Facility for U.S. Commercial Production of Pluvicto
16.3.10. Takeda to Invest 100 Billion JPY in a New Manufacturing Facility for Plasma-Derived Therapies in Japan
16.3.11. Pfizer Acquires Abzena’s Biologic Manufacturing Facility
List of Figures
FIGURE 1. PHARMACEUTICAL MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
FIGURE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. PHARMACEUTICAL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL MANUFACTURING MARKET DYNAMICS
TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ALLERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PULMONARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RENAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 69. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 73. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 76. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 106. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 113. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 114. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 117. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 127. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 128. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 169. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 170. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 173. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 181. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 191. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 195. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 198. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 202. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 205. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 206. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 207. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 209. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 212. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 213. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 216. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 219. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 220. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 221. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 223. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 233. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 237. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 254. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 255. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 258. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 261. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 263. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 265. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 266. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 268. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 269. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 270. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 272. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 273. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 296. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 297. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 298. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 300. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND PHARMACEU

Companies Mentioned

The leading players in the Pharmaceutical Manufacturing market, which are profiled in this report, include:
  • AstraZeneca PLC
  • Lupin Limited
  • Piramal Pharma Limited
  • Asymchem, Inc.
  • Recipharm AB
  • Biocon Limited
  • AbbVie Inc.
  • Bayer AG
  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Pfizer, Inc.
  • Merck KGaA
  • Amgen Inc.
  • Advent Pharma Ltd.
  • Johnson & Johnson Services, Inc.
  • Azurity Pharmaceuticals, Inc.
  • Famar Group
  • Zeon Lifesciences Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Cipla Limited
  • Aenova Group GmbH
  • Boehringer Ingelheim International GmbH
  • Moderna, Inc.
  • Thermo Fisher Scientific Inc.
  • Sun Pharmaceutical Industries Ltd.
  • BioNTech SE
  • Lonza Group AG
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Emcure Pharmaceuticals Limited
  • Veranova, L.P.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Sanofi S.A.
  • Novo Nordisk A/S
  • Glenmark Pharmaceuticals Ltd.
  • Abbott Laboratories
  • GlaxoSmithKline PLC
  • McKesson Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 672.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 1110 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

Pharmaceutical Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Pharmaceutical Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 130 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Market by Component, Technology Type, Formulations, End-user, Therapeutic Area, Applications - Global Forecast 2025-2030 - Product Image

Pharmaceutical Continuous Manufacturing Market by Component, Technology Type, Formulations, End-user, Therapeutic Area, Applications - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Biopharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Monoclonal Antibody, Insulin, Vaccine, Hormone), By Disease, By Drug Type, By Drug Development Type, By Formulation, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biopharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Monoclonal Antibody, Insulin, Vaccine, Hormone), By Disease, By Drug Type, By Drug Development Type, By Formulation, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 225 Pages
  • Global
From
Oral Proteins & Peptides Market by Product Type (Insulin-Based Proteins, Peptide Therapeutics), Formulation (Capsule Formulations, Liquid Formulations, Powder Formulations), Development Stage, Application, End-User - Global Forecast 2025-2030 - Product Image

Oral Proteins & Peptides Market by Product Type (Insulin-Based Proteins, Peptide Therapeutics), Formulation (Capsule Formulations, Liquid Formulations, Powder Formulations), Development Stage, Application, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 164 Pages
  • Global
From

About the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing market is composed of companies that produce drugs and other pharmaceutical products. These products are used to treat and prevent diseases, as well as to improve the quality of life. Pharmaceutical manufacturers are responsible for the research, development, production, and distribution of these products. They must adhere to strict regulations and standards to ensure the safety and efficacy of their products. The Pharmaceutical Manufacturing market is highly competitive, with many large companies vying for market share. Some of the major players in the market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. These companies are involved in the research, development, production, and distribution of pharmaceutical products. They are also involved in the marketing and promotion of their products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.